Stockreport

Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026

Exact Sciences Corporation  (EXAS) 
Last exact sciences corporation earnings: 2/11 04:05 pm Check Earnings Report
PDF The Oncodetect® test expands the role of tumor-informed MRD in triple-negative breast cancerThe Cancerguard® test demonstrates improved early-stage multi-cancer detectio [Read more]